Quant/pattern bias: Similar-pattern analysis suggests higher probability of mild declines (next day -2.58% chance-weighted; next week/month slightly negative), arguing against chasing now.
Positioning/Sentiment: Open interest put/call ratio 0.02 (puts 12 vs calls 746) → extremely call-heavy, generally bullish sentiment/hedging light.
Activity: Today’s options volume is 1 contract (puts 0) → sentiment signal is based more on OI than fresh flow.
Volatility: IV30 ~59.82 vs historical vol ~36.16 → options imply elevated moves; however IV percentile 30 / IV rank 16 suggests IV is not extreme relative to its own history.
Takeaway: Options market leans bullish, but low volume reduces signal strength.
Technical Summary
Sell
7
Buy
6
Positive Catalysts
scheduled 2026-02-19 after hours (could re-rate shares if margins/profitability inflect).
Neutral/Negative Catalysts
Insider activity: Insiders are selling; selling amount up ~521.10% over the last month (clear sentiment/overhang risk).
Near-term technical/quant tilt: Price below pivot with a negative (though improving) MACD; pattern-based outlook skews slightly downward.
No recent news catalysts in the last week to spark immediate upside momentum.
Profitability trend: Net income and EPS deteriorated sharply YoY in the latest quarter.
Financial Performance
Latest reported quarter: 2025/Q3.
Revenue: $134.269M, up +15.84% YoY (solid top-line growth).
Profitability: Net income -$0.267M, down -96.60% YoY; EPS -$0.01, down -94.12% YoY (earnings power weakened despite revenue growth).
Margins: Gross margin 75.47%, up +0.79% YoY (slight improvement, but not yet translating into bottom-line gains).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Latest action (2025-12-16): JPMorgan raised price target to $48 (from $42) and maintained Overweight.
Wall Street pros: Raised PT implies improving confidence in trajectory/valuation upside from current ~$38.
Wall Street cons: Recent quarter shows profitability softness (net income/EPS down sharply YoY), which can cap multiple expansion until earnings inflect.
Influential/politician activity: No recent congress trading data available in the last 90 days.
Wall Street analysts forecast ATRC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ATRC is 51.83 USD with a low forecast of 45 USD and a high forecast of 64 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Analyst Rating
Wall Street analysts forecast ATRC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ATRC is 51.83 USD with a low forecast of 45 USD and a high forecast of 64 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Buy
0 Hold
0 Sell
Strong Buy
Current: 36.200
Low
45
Averages
51.83
High
64
Current: 36.200
Low
45
Averages
51.83
High
64
JPMorgan
NULL -> Overweight
maintain
$42 -> $48
AI Analysis
2025-12-16
Reason
JPMorgan
Price Target
$42 -> $48
AI Analysis
2025-12-16
maintain
NULL -> Overweight
Reason
JPMorgan raised the firm's price target on AtriCure to $48 from $42 and keeps an Overweight rating on the shares. The firm updated the company's model.
Canaccord
William Plovanic
Buy
maintain
$51 -> $53
2025-07-30
Reason
Canaccord
William Plovanic
Price Target
$51 -> $53
2025-07-30
maintain
Buy
Reason
Canaccord analyst William Plovanic raised the firm's price target on AtriCure to $53 from $51 and keeps a Buy rating on the shares. The firm said they reported a very solid Q2, with strength across the rest of the business more than offsetting further degradation of US EPi-Sense/Hybrid. The target increase reflects comp group multiple expansion and increased expectations.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ATRC
